{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:51Z","timestamp":1790882391991,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02702-9","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:27:16Z","timestamp":1769783236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ER\u03b1, DOT1L and menin"],"prefix":"10.1186","volume":"24","author":[{"given":"Viola","family":"Melone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Palo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Memoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ianniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoush","family":"Nikzaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lamberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Nassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"4","key":"2702_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner JE, Hnisz D, Young RA. Transcriptional addiction in cancer. Cell. 2017;168(4):629\u201343.","journal-title":"Cell"},{"issue":"1","key":"2702_CR2","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12(1):1786.","journal-title":"Nat Commun"},{"issue":"10","key":"2702_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R. ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol. 2015;12(10):573\u201383.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2702_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, et al. The genomic landscape of Endocrine-Resistant advanced breast cancers. Cancer Cell. 2018;34(3):427\u2013e4386.","journal-title":"Cancer Cell"},{"key":"2702_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers15194689","volume":"15","author":"P Miziak","year":"2023","unstructured":"Miziak P, Baran M, B\u0142aszczak E, Przybyszewska-Podstawka A, Ka\u0142afut J, Smok-Kalwat J, et al. Estrogen receptor signaling in breast cancer. Cancers (Basel). 2023;15:19.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2702_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","volume":"10","author":"J Song","year":"2025","unstructured":"Song J, Yang P, Chen C, Ding W, Tillement O, Bai H, et al. Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance. Signal Transduct Target Ther. 2025;10(1):219.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2702_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-024-02071-2","volume":"23","author":"A Salvati","year":"2024","unstructured":"Salvati A, Giurato G, Lamberti J, Terenzi I, Crescenzo L, Melone V, et al. Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers. Mol Cancer. 2024;23(1):160.","journal-title":"Mol Cancer"},{"issue":"1","key":"2702_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1186\/s12967-025-06856-x","volume":"23","author":"A Salvati","year":"2025","unstructured":"Salvati A, Melone V, Giordano A, Lamberti J, Palumbo D, Palo L, et al. Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies. J Transl Med. 2025;23(1):837.","journal-title":"J Transl Med"},{"issue":"1","key":"2702_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13058-022-01547-7","volume":"24","author":"A Salvati","year":"2022","unstructured":"Salvati A, Melone V, Sellitto A, Rizzo F, Tarallo R, Nyman TA, et al. Combinatorial targeting of a chromatin complex comprising Dot1L, Menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer. Breast Cancer Res. 2022;24(1):52.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2702_CR10","doi-asserted-by":"publisher","first-page":"eaav5590","DOI":"10.1126\/sciadv.aav5590","volume":"5","author":"G Nassa","year":"2019","unstructured":"Nassa G, Salvati A, Tarallo R, Gigantino V, Alexandrova E, Memoli D, et al. Inhibition of histone methyltransferase DOT1L silences ER\u03b1 gene and blocks proliferation of antiestrogen-resistant breast cancer cells. Sci Adv. 2019;5(2):eaav5590.","journal-title":"Sci Adv"},{"issue":"1","key":"2702_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41597-019-0179-2","volume":"6","author":"G Nassa","year":"2019","unstructured":"Nassa G, Giurato G, Salvati A, Gigantino V, Pecoraro G, Lamberti J, et al. The RNA-mediated Estrogen receptor \u03b1 interactome of hormone-dependent human breast cancer cell nuclei. Sci Data. 2019;6(1):173.","journal-title":"Sci Data"},{"key":"2702_CR12","doi-asserted-by":"publisher","unstructured":"Melone V, Salvati A, Brusco N, Alexandrova E, D\u2019Agostino Y, Palumbo D et al. Functional relationships between long Non-Coding RNAs and Estrogen receptor alpha: A new frontier in Hormone-Responsive breast cancer management. Int J Mol Sci. 2023;24(2). https:\/\/doi.org\/10.3390\/ijms24021145.","DOI":"10.3390\/ijms24021145"},{"issue":"1","key":"2702_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41419-025-07423-4","volume":"16","author":"V Melone","year":"2025","unstructured":"Melone V, Palumbo D, Palo L, Brusco N, Salvati A, Tarallo A, et al. LncRNA PVT1 links Estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer. Cell Death Dis. 2025;16(1):80.","journal-title":"Cell Death Dis"},{"key":"2702_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.omtn.2021.08.005","volume":"25","author":"H Jin","year":"2021","unstructured":"Jin H, Du W, Huang W, Yan J, Tang Q, Chen Y, et al. LncRNA and breast cancer: progress from identifying mechanisms to challenges and opportunities of clinical treatment. Mol Ther Nucleic Acids. 2021;25:613\u201337.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"2702_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10549-009-0581-0","volume":"122","author":"H Imachi","year":"2010","unstructured":"Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, et al. Menin, a product of the MENI gene, binds to Estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for Tamoxifen resistance. Breast Cancer Res Treat. 2010;122(2):395\u2013407.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"2702_CR16","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1158\/0008-5472.CAN-05-4461","volume":"66","author":"KMA Dreijerink","year":"2006","unstructured":"Dreijerink KMA, Mulder KW, Winkler GS, H\u00f6ppener JWM, Lips CJM, Timmers HTM. Menin links Estrogen receptor activation to histone H3K4 trimethylation. Cancer Res. 2006;66(9):4929\u201335.","journal-title":"Cancer Res"},{"key":"2702_CR17","doi-asserted-by":"publisher","unstructured":"Liu SJ, Horlbeck MA, Cho SW, Birk HS, Malatesta M, He D et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017;355(6320). https:\/\/doi.org\/10.1126\/science.aah7111.","DOI":"10.1126\/science.aah7111"},{"issue":"20","key":"2702_CR18","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.cell.2021.08.036","volume":"184","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huangyang P, Wang Y, Xue L, Devericks E, Nguyen HG, et al. ER\u03b1 is an RNA-binding protein sustaining tumor cell survival and drug resistance. Cell. 2021;184(20):5215\u2013e522917.","journal-title":"Cell"},{"key":"2702_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0076-6879(95)55036-4","volume":"255","author":"AB Vojtek","year":"1995","unstructured":"Vojtek AB, Hollenberg SM. Ras-Raf interaction: two-hybrid analysis. Meth Enzymol. 1995;255:331\u201342.","journal-title":"Meth Enzymol"},{"issue":"3","key":"2702_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng0797-277","volume":"16","author":"M Fromont-Racine","year":"1997","unstructured":"Fromont-Racine M, Rain JC, Legrain P. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat Genet. 1997;16(3):277\u201382.","journal-title":"Nat Genet"},{"issue":"43","key":"2702_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2702_CR22","doi-asserted-by":"crossref","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","DOI":"10.1093\/nar\/gkac1000"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02702-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:02:49Z","timestamp":1771974169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02702-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2702"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02702-9","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}